Morning Overview on MSN
Scientists uncover genetic switch that makes pancreatic cancer chemo-proof
Researchers at Duke-NUS Medical School have identified a molecular switch controlled by the protein GATA6 that determines whether pancreatic cancer cells respond to chemotherapy or become resistant.
Ellis Bio, a developer of next-generation epigenomics technologies, today announced the official commercial launch of its SuperMethyltm Max Bisulfite Conversion Kit, a new and gentle methyl conversion ...
Background Monogenic disorders are a major cause of fetal structural anomalies. Most genetic diagnoses involve de novo, biallelic or X linked variants; however, inherited variants in autosomal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results